No competitor review covers this context, but it directly affects every MEDVi patient
GLP-1 medications slow gastric emptying, keeping stomach contentsincluding gastric acidin the digestive system longer
When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period
Qual Life Res
You can explore our approach to weight management at Check Your Eligibility If you want to learn whether GLP-1 treatment is appropriate for your health needs and receive personalized guidance on nutrition and exercise during treatment, you can start by completing Mochis eligibility questionnaire
While these medications have marketing authorisations for specific indications, NHS access is governed by NICE technology appraisals, which set narrower eligibility criteria than the marketing authorisation
